AviadoBio.
AviadoBio develops gene therapies for neurological conditions, leveraging its understanding of the brain and proprietary delivery technologies. The company aims to overcome challenges in delivering gene therapies to the brain, potentially halting or reversing neurodegenerative diseases. Its innovative approach is based on pioneering research from King's College London and the UK Dementia Research Institute.
Buy Funded Startups lists
Funding Round: Equity
Funding Amount: $20M
Date: 08-Oct-2024
Investors: Astellas Pharma Inc., New Enterprise Associates (NEA), Monograph Capital, F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), SV Health Investor’s Dementia Discovery Fund (DDF), Advent Life Sciences, EQT Life Sciences (Dementia Fund), LifeArc Ventures
Markets: Biotechnology, Gene Therapy, Neuroscience, Healthtech
HQ: London, England, United Kingdom
Founded: 2019
Website: https://www.aviadobio.com/
LinkedIn: https://www.linkedin.com/company/aviadobio/
Twitter: https://twitter.com/aviadobio?lang=en
Facebook: https://www.facebook.com/AviadoBio
Crunchbase: https://www.crunchbase.com/organization/aviadobio
Leave a Comment
Comments
No comments yet.